Therapix Biosciences

Developing cannabinoid-based therapies for CNS disorders

placeGivatayim, Tel Aviv, Israel calendar_todayFounded 2014 language therapixbio.com

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 194 times.

YearFilings
20131
20152
20163
20172
20184
20193
20203
20212
20221
20242

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon